Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]
Eur J Heart Fail
.
2016 Jun;18(6):727.
doi: 10.1002/ejhf.591.
Authors
Stefan D Anker
1
,
Stefan Schroeder
2
,
Dan Atar
3
,
Jeroen J Bax
4
,
Claudio Ceconi
5
,
Martin R Cowie
6
,
Adam Crisp
7
,
Fabienne Dominjon
8
,
Ian Ford
9
,
Hossein-Ardeschir Ghofrani
10
11
12
,
Savion Gropper
13
,
Gerhard Hindricks
14
,
Mark A Hlatky
15
,
Richard Holcomb
16
,
Narimon Honarpour
17
,
J Wouter Jukema
4
,
Albert M Kim
18
,
Michael Kunz
2
,
Martin Lefkowitz
19
,
Chantal Le Floch
8
,
Ulf Landmesser
20
,
Theresa A McDonagh
21
,
John J McMurray
22
,
Bela Merkely
23
,
Milton Packer
24
,
Krishna Prasad
25
,
James Revkin
18
,
Giuseppe M C Rosano
26
27
,
Ransi Somaratne
17
,
Wendy Gattis Stough
28
,
Adriaan A Voors
29
,
Frank Ruschitzka
30
Affiliations
1
Innovative Clinical Trials, Department of Cardiology & Pneumology, University Medical Center Göttingen (UMG), Germany.
2
Bayer Pharma AG, Berlin, Germany.
3
Department of Cardiology B, Oslo University Hospital Ulleval and University of Oslo, Norway.
4
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
5
Unit of Cardiology, Hospital of Desenzano del Garda, Desenzano del Garda, Italy.
6
National Heart and Lung Institute, Imperial College London, London, UK.
7
GlaxoSmithKline, Middlesex, UK.
8
Servier International, Paris, France.
9
Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
10
University of Giessen and Marburg Lung Center, UGMLC [member of the German Center for Lung Research (DZL)], Giessen, Germany.
11
Kerckhoff-Klinik Bad Nauheim, Germany.
12
Imperial College London, UK.
13
Boehringer-Ingelheim GmBH & Co. KG, Ingelheim, Germany.
14
Department of Electrophysiology, Heart Center, University of Leipzig, Leipzig, Germany.
15
Stanford University School of Medicine, Stanford, CA, USA.
16
Independent Biostatistician, Minneapolis, MN, USA.
17
Amgen, Inc., Thousand Oaks, CA, USA.
18
Pfizer, Inc., Cambridge, MA, USA.
19
Novartis Pharmaceuticals, East Hanover, NJ, USA.
20
Department of Cardiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
21
King's College Hospital, London, UK.
22
BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
23
Semmelweis University Heart and Vascular Center, Budapest, Hungary.
24
Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
25
United Kingdom Medicines and Healthcare Products Regulatory Agency, London, UK.
26
IRCCS San Raffaele Hospital Roma, Rome, Italy.
27
Cardiovascular and Cell Sciences Institute, St. George's University of London, London, UK.
28
Campbell University College of Pharmacy and Health Sciences, NC, USA.
29
University of Groningen, Groningen, The Netherlands.
30
Department of Cardiology, Heart Failure Clinic and Transplantation, University Heart Center Zurich, Zurich, Switzerland.
PMID:
27324688
DOI:
10.1002/ejhf.591
No abstract available
Publication types
Published Erratum